Bio Pharma Dive
OCTOBER 23, 2023
The trial, which is ongoing in the U.K. and New Zealand, has been on hold in the U.S. since late last year as the FDA sought more details on Verve’s in vivo treatment for heart disease.
Pharmaceutical Technology
OCTOBER 23, 2023
At ESMO 2023, interim results from the Phase III LITESPARK-005 trial evaluating MSD’s Welireg (belzutifan) as a treatment for patients with previously treated advanced clear cell renal cell carcinoma (RCC) were presented.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Bio Pharma Dive
OCTOBER 23, 2023
The clearance of the pentavalent shot Penbraya adds to Pfizer’s infectious disease portfolio as it adjusts to slumping COVID-19 vaccine sales.
Pharmaceutical Technology
OCTOBER 23, 2023
What is quantum computing and what does it mean for business. Quantum computing has emerged from a hype cycle with continued investment.
Speaker: Simran Kaur, Founder & CEO at Tattva Health Inc.
The healthcare landscape is being revolutionized by AI and cutting-edge digital technologies, reshaping how patients receive care and interact with providers. In this webinar led by Simran Kaur, we will explore how AI-driven solutions are enhancing patient communication, improving care quality, and empowering preventive and predictive medicine. You'll also learn how AI is streamlining healthcare processes, helping providers offer more efficient, personalized care and enabling faster, data-driven
Bio Pharma Dive
OCTOBER 23, 2023
A combination of Seagen and Astellas’ antibody-drug conjugate Padcev with Merck’s Keytruda dramatically improved survival in first-line bladder cancer.
Pharma Times
OCTOBER 23, 2023
STARMAP will accelerate the selection of AZ’s best molecule candidates - News - PharmaTimes
Clinical Research Informer brings together the best content for clinical researchers from the widest variety of industry thought leaders.
Pharmaceutical Technology
OCTOBER 23, 2023
The combination’s ORR had a noticeable improvement over the data demonstrated by Keytruda in the first-line metastatic NSCLC setting.
Bio Pharma Dive
OCTOBER 23, 2023
Effective marketing measurement requires objectivity, connected data, transparency, a track record of innovation and a proven ability to execute.
Pharmaceutical Technology
OCTOBER 23, 2023
Less than a year after Roivant purchased the IBD drug from Pfizer, it is selling it on for massive profit.
Bio Pharma Dive
OCTOBER 23, 2023
The Swiss pharmaceutical company has agreed to buy Televant, a company set up by Roivant and Pfizer to develop a promising inflammatory bowel disease treatment.
Pharmaceutical Technology
OCTOBER 23, 2023
Businesses are commonly unaware of the threats generative AI poses to cybersecurity and data privacy, new research has suggested.
Bio Pharma Dive
OCTOBER 23, 2023
McEvoy is leaving the company after 27 years to pursue other opportunities. Tim Schmid will now lead the MedTech business.
Pharma Times
OCTOBER 23, 2023
STARMAP will accelerate the selection of AZ’s best molecule candidates - News - PharmaTimes
Bio Pharma Dive
OCTOBER 23, 2023
Rare disease drug development is a unique and challenging field that demands strategic development expertise and uniting of the various stakeholders working toward the same goal.
Advertisement
White paper that delves into the complex topic of Decentralized Clinical Trials and how to master them within the confines of FDA Regulations
Pharma Times
OCTOBER 23, 2023
On 10 to 11 October 2023, the seventh FlyPharma Conference Europe successfully concluded in Vienna, Austria - News - PharmaTimes
Pharmaceutical Technology
OCTOBER 23, 2023
H2O Therapeutics’s Parky app is a symptom tracker app designed to quantify the kinematics of movement disorder symptoms in PD patients.
pharmaphorum
OCTOBER 23, 2023
Embracing generative AI will enhance, not replace, the humanity in commercial models Mike.
Pharmaceutical Technology
OCTOBER 23, 2023
Hengst consolidates expertise in industrial air filtration bringing DELBAG and Nordic Air Filtration under the umbrella brand Hengst Filtration.
Fierce Pharma
OCTOBER 23, 2023
Regeneron and Sanofi are anxious to bring Dupixent as an answer for chronic spontaneous urticaria (CSU), a severe inflammatory condition that causes hives and deep swelling on or under the skin.
Pharmaceutical Technology
OCTOBER 23, 2023
As it builds momentum towards a Phase IIa study for its NASH drug, Aligos aims to be a THR-β agonist market contender.
pharmaphorum
OCTOBER 23, 2023
Understanding the complex rare disease and specialty pharmaceutical landscape Mike.
Pharmaceutical Technology
OCTOBER 23, 2023
BioMarin has seen the label for its achondroplasia drug expand following two clinical trials that saw positive growth in children living with the condition.
Advertisement
This new white paper defines and details the impact of Decentralized Clinical Trials on the Pharmaceutical industry and how the impact can be measured along with steps companies can take to ensure adoption.
pharmaphorum
OCTOBER 23, 2023
ESMO: Trials end 20-year hiatus in cervical cancer therapy Phil.
Pharmaceutical Technology
OCTOBER 23, 2023
The Remicade biosimilar is forecasted to have sales of $2.3bn by 2029 as a subcutaneous form is approved for the US market.
pharmaphorum
OCTOBER 23, 2023
Rumour confirmed as Roche buys Telavant for $7.1bn Phil.
Pharmaceutical Technology
OCTOBER 23, 2023
Penbraya reduces the total number of doses needed for adolescents to be fully vaccinated against the leading serogroups that cause meningococcal disease.
Advertisement
Planning on running clinical trials in Japan? How can you reliably supply these studies? Discover Catalent’s clinical supply packaging facility in Shiga, Japan. Strategically located between Tokyo and Osaka, and one of largest in Japan, this 6,000 square meter facility offers comprehensive services including primary and secondary clinical packaging and labelling, comparator sourcing, cold chain storage, local and global distribution, local language support and white glove service to support stud
Fierce Pharma
OCTOBER 23, 2023
Five pharmaceutical companies, including the global player Boehringer Ingelheim, have landed in hot water for running a "cartel" to dominate the market for a specific drug ingredient in Europe. | Authorities said the companies agreed to set minimum prices, allocated business and more. Boehringer Ingelheim was hit with the largest fine among the group.
Pharmaceutical Technology
OCTOBER 23, 2023
On 2 October, Eli Lilly announced that the US Food and Drug Administration (FDA) had issued a complete response letter (CRL) regarding the biologic license application (BLA) for its anti-interleukin (IL)-13 biologic lebrikizumab for the treatment of adults and adolescents (12 and older) with moderate-to-severe atopic dermatitis (AD).
pharmaphorum
OCTOBER 23, 2023
ESMO: Immunotherapy combos extend lives in bladder cancer Phil.
Fierce Pharma
OCTOBER 23, 2023
With a $385 million settlement, Suboxone maker Indivior is moving to wrap up years of antitrust litigation tied to its opioid addiction treatment. | The deal follows previous settlements worth $102 million and $30 million with two other claimant groups.
Advertisement
Clinical trial data management is increasingly challenging as studies grow in complexity. Quickly accessing and analyzing study data is vital for assessing trial progress and patient safety. In this paper, we explore real-time data access and analysis for proactive study management. We investigate using adverse event (AE) data to monitor safety and discuss a clinical analytics platform that supports collaboration and data review workflows.
Expert insights. Personalized for you.
344 
Let's personalize your content